D&D Pharmatech
Latest round
- Series C
Last raised
- Oct 2021
Total raised
- $187M
Investors
- 12
About D&D Pharmatech
Based in Seongnam-si, South Korea, and founded in 2014 by CEO Seulki lee, D&D Pharmatech Inc. operates as a pharmaceutical company that develops therapeutics for the treatment of neurodegenerative diseases, fibrotic diseases, and metabolic diseases, as well as molecular imaging. In May 2024, D&D Pharmatech Inc.1 million shares at KRW 33,000 per share, above the expected price range of KRW 22,000 and KRW 26,000 on the KOSDAQ. D&D Pharmatech Inc. focuses on drug discovery program, targeting metabolic diseases, including obesity, diabetes, and non-alcoholic steatohepatitis (NASH). Its PEGylation and oral peptide platform technologies to develop DD01, which is a GLP-1/Glucagon dual receptor agonist and reduces liver fat content in patients with obesity, diabetes, and NASH. The company offers neurological research into treatments for neurodegenerative diseases such as Parkinson's and Alzheimer's. Its lead asset, NLY01, is a GLP-1R agonist targeting neuroinflammation across multiple therapeutic areas.
Who invested in D&D Pharmatech
12 investors across 3 rounds
See all investors in D&D Pharmatech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about D&D Pharmatech
Who invested in D&D Pharmatech?
D&D Pharmatech has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has D&D Pharmatech raised?
D&D Pharmatech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did D&D Pharmatech last raise money?
D&D Pharmatech's most recent round on record is a Series C, in Oct 2021.
What does D&D Pharmatech do?
Based in Seongnam-si, South Korea, and founded in 2014 by CEO Seulki lee, D&D Pharmatech Inc.
Where is D&D Pharmatech headquartered?
D&D Pharmatech is headquartered in Seongnam, South Korea.
Which VCs invest in companies like D&D Pharmatech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at D&D Pharmatech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like D&D Pharmatech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.